Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleCLINICAL INVESTIGATIONS

Effect of Intramyocardial Injection of Autologous Bone Marrow–Derived Mononuclear Cells on Perfusion, Function, and Viability in Patients with Drug-Refractory Chronic Ischemia

Saskia L.M.A. Beeres, Jeroen J. Bax, Petra Dibbets, Marcel P.M. Stokkel, Katja Zeppenfeld, Willem E. Fibbe, Ernst E. van der Wall, Martin J. Schalij and Douwe E. Atsma
Journal of Nuclear Medicine April 2006, 47 (4) 574-580;
Saskia L.M.A. Beeres
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeroen J. Bax
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Petra Dibbets
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcel P.M. Stokkel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katja Zeppenfeld
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Willem E. Fibbe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ernst E. van der Wall
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin J. Schalij
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douwe E. Atsma
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1. 

    SPECT images (vertical long axes) from representative patient. 99mTc-Tetrofosmin SPECT shows stress-induced ischemia at baseline in inferior wall (arrow). At 3-mo follow-up, ischemia in inferior wall has resolved. Metabolic imaging shows normal 18F-FDG uptake at baseline and 3-mo follow-up in that region, indicating no scar formation after intramyocardial injection of bone marrow–derived mononuclear cells.

  • FIGURE 2. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2. 

    Patients' segmental stress and rest scores improved significantly 3 mo after autologous bone marrow–derived mononuclear cell injection. Magnitude of increase in stress score was significantly higher as observed for rest score.

  • FIGURE 3. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3. 

    Patients' gated 99mTc-tetrofosmin SPECT segmental stress and rest scores in injected and noninjected segments. (A) Patients' segmental stress score improved in injected and noninjected segments. Improvement in injected segments was more pronounced than improvement in noninjected segments. (B) There was a trend toward improvement in rest score in injected and noninjected segments. Magnitude of improvement in rest score was similar in injected and noninjected segments.

Tables

  • Figures
    • View popup
    TABLE 1

    Clinical Characteristics of Study Population

    Parametern%
    Age (y)64 ± 10
    Sex (M)21/2584
    Systemic hypertension12/2548
    Diabetes mellitus13/2552
     Insulin dependent7/2528
     Non–insulin dependent6/2524
    Hyperlipidemia22/2588
    Smoking2/258
    Coronary artery disease in family18/2572
    Body mass index28 ± 4
    Prior myocardial infarction18/2572
    Prior percutaneous coronary intervention19/2576
    Prior coronary artery bypass grafting22/2588
    Current medication
     Nitrates25/25100
     β-Blockers23/2592
     Calcium channel blockers18/2572
     Statins24/2596
     Angiotensin-converting enzyme inhibitors19/2576
    • View popup
    TABLE 2

    Stress Test Data

    Stress test dataBaseline3-mo follow-upP value
    Level of stress achieved (W)130 ± 32135 ± 350.10
    Heart rate at rest (bpm)73 ± 1570 ± 15NS
    SBP at rest (mm Hg)136 ± 18136 ± 18NS
    DBP at rest (mm Hg)78 ± 1175 ± 13NS
    Maximal heart rate at stress (bpm)105 ± 29103 ± 30NS
    Maximal SBP at stress (mm Hg)154 ± 32157 ± 31NS
    Maximal DBP at stress (mm Hg)78 ± 1276 ± 15NS
    • bpm = beats per minute; SBP = systolic blood pressure; DBP = diastolic blood pressure.

    • View popup
    TABLE 3

    LV Ejection Fraction and Volumes as Assessed by Gated 99mTc-Tetrofosmin SPECT

    LV ejection fraction and volumesBaseline3-mo follow-upP value
    LV ejection fraction (%)47.6 ± 13.554.1 ± 16.9<0.01
    LV end-systolic volume (mL)81 ± 6875 ± 70<0.01
    LV end-diastolic volume (mL)137 ± 80139 ± 82NS
    • View popup
    TABLE 4

    Perfusion in Injected and Noninjected Segments

    SegmentsImproved perfusionNo improved perfusionP value
    Injected48/9143/91<0.01
    Noninjected45/334289/334
    • Improved perfusion ≥ 1 point increase in stress or rest perfusion.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 47 (4)
Journal of Nuclear Medicine
Vol. 47, Issue 4
April 2006
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Effect of Intramyocardial Injection of Autologous Bone Marrow–Derived Mononuclear Cells on Perfusion, Function, and Viability in Patients with Drug-Refractory Chronic Ischemia
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Effect of Intramyocardial Injection of Autologous Bone Marrow–Derived Mononuclear Cells on Perfusion, Function, and Viability in Patients with Drug-Refractory Chronic Ischemia
Saskia L.M.A. Beeres, Jeroen J. Bax, Petra Dibbets, Marcel P.M. Stokkel, Katja Zeppenfeld, Willem E. Fibbe, Ernst E. van der Wall, Martin J. Schalij, Douwe E. Atsma
Journal of Nuclear Medicine Apr 2006, 47 (4) 574-580;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Effect of Intramyocardial Injection of Autologous Bone Marrow–Derived Mononuclear Cells on Perfusion, Function, and Viability in Patients with Drug-Refractory Chronic Ischemia
Saskia L.M.A. Beeres, Jeroen J. Bax, Petra Dibbets, Marcel P.M. Stokkel, Katja Zeppenfeld, Willem E. Fibbe, Ernst E. van der Wall, Martin J. Schalij, Douwe E. Atsma
Journal of Nuclear Medicine Apr 2006, 47 (4) 574-580;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Repeat Cell Therapy for Refractory Angina: Deja vu All Over Again?
  • Repeated Intramyocardial Bone Marrow Cell Injection in Previously Responding Patients With Refractory Angina Again Improves Myocardial Perfusion, Anginal Complaints, and Quality of Life
  • In Vivo Functional and Transcriptional Profiling of Bone Marrow Stem Cells After Transplantation Into Ischemic Myocardium
  • Imaging: Guiding the Clinical Translation of Cardiac Stem Cell Therapy
  • Treatment of Refractory Angina
  • Effect of Progenitor Cells on Myocardial Perfusion and Metabolism in Patients After Recanalization of a Chronically Occluded Coronary Artery
  • Direct Intramyocardial But Not Intracoronary Injection of Bone Marrow Cells Induces Ventricular Arrhythmias in a Rat Chronic Ischemic Heart Failure Model
  • Role of Imaging in Cardiac Stem Cell Therapy
  • Extent of Viability to Predict Response to Cardiac Resynchronization Therapy in Ischemic Heart Failure Patients
  • Google Scholar

More in this TOC Section

  • Feasibility of Ultra-Low-Activity 18F-FDG PET/CT Imaging Using a Long–Axial-Field-of-View PET/CT System
  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
Show more Clinical Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire